Placental polar lipid composition is associated with placental gene expression and neonatal body composition

https://doi.org/10.1016/j.bbalip.2021.158971Get rights and content

Highlights

  • Placentas of different sizes have specific differences in polar lipid composition.

  • Placental polar lipid composition was related to placental weight and neonatal lean mass.

  • Placental polar lipid composition was related to placental gene expression.

Abstract

The polar-lipid composition of the placenta reflects its cellular heterogeneity and metabolism. This study explored relationships between placental polar-lipid composition, gene expression and neonatal body composition.

Placental tissue and maternal and offspring data were collected in the Southampton Women's Survey. Lipid and RNA were extracted from placental tissue and polar lipids measured by mass spectrometry, while gene expression was assessed using the nCounter analysis platform. Principal component analysis was used to identify patterns within placental lipid composition and these were correlated with neonatal body composition and placental gene expression.

In the analysis of placental lipids, the first three principal components explained 19.1%, 12.7% and 8.0% of variation in placental lipid composition, respectively. Principal component 2 was characterised by high principal component scores for acyl-alkyl-glycerophosphatidylcholines and lipid species containing DHA. Principal component 2 was associated with placental weight and neonatal lean mass; this component was associated with gene expression of APOE, PLIN2, FATP2, FABP4, LEP, G0S2, PNPLA2 and SRB1. Principal components 1 and 3 were not related to birth outcomes but they were associated with the gene expression of lipid related genes. Principal component 1 was associated with expression of LEP, APOE, FATP2 and ACAT2. Principal component 3 was associated with expression of PLIN2, PLIN3 and PNPLA2.

This study demonstrates that placentas of different sizes have specific differences in polar-lipid composition and related gene expression. These differences in lipid composition were associated with birth weight and neonatal lean mass, suggesting that placental lipid composition may influence prenatal lean mass accretion.

Introduction

Placental function and substrate supply are primary determinants of fetal development and have consequences for health during pregnancy and across the life course [1,2]. Polar lipid composition of the placenta may reflect multiple factors including maternal fatty acid supply, placental metabolism and placental cellular composition. These factors could affect placental function and thus the intrauterine environment and fetal development.

Polar lipids include different classes of phospholipids, sphingolipids found within the membranes and carnitines involved in lipid metabolism [3]. These lipids play important roles in the structure and function of lipid membranes. As specific lipids may be concentrated within lipid microdomains (e.g. sphingomyelins in lipid rafts [4]), within specific organelles or cell types their relative abundance may not reflect their biological importance to placental function. Fatty acids taken up by the placenta from maternal plasma may be incorporated into placental lipid pools or transported to the fetus [5,6]. Phospholipids are the major lipid pool within the placenta and there is evidence of selective partitioning of fatty acids into different placental lipid pools [7,8].

Different placental cell populations and subcellular membrane fractions have different lipid compositions which all contribute to what is measured in the lipid extracted from a tissue [9]. Changes in whole placental lipid composition may be explained by differences in cellular composition of the placenta, changes in placental lipid metabolism or altered maternal supply. The regulation of placental lipid metabolism within the placenta is not well understood, but there is evidence that it is altered in obese mothers [10,11].

This study explores how placental polar lipid composition and lipid-associated gene expression are related to birth outcomes, specifically placental weight and birthweight and neonatal body composition.

Section snippets

Methods

The study was conducted according to the guidelines of the Declaration of Helsinki, and the Southampton and South West Hampshire Research Ethics Committee approved all procedures (276/97, 307/97, 089/99, 153/99, 005/03/t, 06/Q1702/104). Written informed consent was obtained from all participating women.

Cohort data

Maternal and neonatal data for the 99 participating mother-child pairs studied are provided in Table 1.

Lipidomic data

The lipidomic analysis provided information on 75 polar lipid species including Carn, PC.aa, PC.ae, Lyso.PC and SM in samples from the 99 placentas (Fig. 1). The full list of species measured, and summary values are provided in Supplementary Table S3. All analyses were performed on the % data. To reduce the complexity of the data principal component analysis was performed on the percentage

Discussion

This study found relationships between placental lipid composition and placental weight, birth weight and neonatal lean mass. As fetal growth is a product of placental function, elucidating the role of these lipids in the placenta may highlight placental determinants of fetal growth. Furthermore, the relationships between placental lipid composition and the expression of lipid-related genes suggest underlying regulation of lipid composition and gene expression.

The lipid composition of the

CRediT authorship contribution statement

Olaf Uhl: Investigation, Formal analysis, Writing – original draft, Writing – review & editing. Rohan M. Lewis: Funding acquisition, Resources, Formal analysis, Writing – original draft, Writing – review & editing, Supervision. Birgit Hirschmugl: Investigation, Formal analysis, Writing – review & editing. Sarah Crozier: Formal analysis, Writing – original draft, Writing – review & editing. Hazel Inskip: Resources, Writing – review & editing. Antonio Gazquez: Methodology, Writing – review &

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

This work has been financially supported in part by the European Union Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition (grant agreement n°289346) and the European Research Council Advanced Grant META-GROWTH (ERC-2012-AdG 322605). BK and KMG are supported by the European Union Erasmus+ Capacity-Building ENeASEA Project. BK is the Else Kröner-Seniorprofessor of Paediatrics at LMU supported by the Else Kroner-Fresenius Foundation and LMU Munich. KMG is supported by the UK

References (23)

  • O.C. Watkins et al.

    Metabolism of 13C-labeled fatty acids in term human placental explants by liquid chromatography-mass spectrometry

    Endocrinology

    (2019)
  • 1

    Olaf Uhl and Rohan M Lewis contributed equally and share the first authorship.

    View full text